Demi-Cof Interactions
There are 714 drugs known to interact with Demi-Cof (chlorpheniramine / codeine / phenylephrine / potassium iodide), along with 28 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 170 are major, 541 are moderate, and 3 are minor.
- View all 714 medications that may interact with Demi-Cof
- View Demi-Cof alcohol/food interactions (1)
- View Demi-Cof disease interactions (28)
Most frequently checked interactions
View interaction reports for Demi-Cof (chlorpheniramine / codeine / phenylephrine / potassium iodide) and the medicines listed below.
- Ativan (lorazepam)
- Ativan (lorazepam)
- Demazin (chlorpheniramine / phenylpropanolamine)
- Demazin (chlorpheniramine / phenylpropanolamine)
- Lamictal (lamotrigine)
- Lamictal (lamotrigine)
- Lasix (furosemide)
- Lasix (furosemide)
- Strattera (atomoxetine)
- Strattera (atomoxetine)
- Topamax (topiramate)
- Topamax (topiramate)
- Zofran (ondansetron)
- Zofran (ondansetron)
Demi-Cof alcohol/food interactions
There is 1 alcohol/food interaction with Demi-Cof (chlorpheniramine / codeine / phenylephrine / potassium iodide).
Demi-Cof disease interactions
There are 28 disease interactions with Demi-Cof (chlorpheniramine / codeine / phenylephrine / potassium iodide) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- hyperthyroidism
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- heart disease
- dermatitis herpetiformis
- vasculitis
- BPH
- diabetes
- glaucoma
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.